Type 1 Diabetes

Type 1 diabetes, formerly called juvenile diabetes or insulin-dependent diabetes, is usually first diagnosed in children, teenagers, or young adults. In this form of diabetes, the beta cells of the pancreas no longer make insulin because the body’s immune system has attacked and destroyed them. Treatment for type 1 diabetes includes taking insulin shots or using an insulin pump, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.
What is Type 1 Diabetes?

Type 1 diabetes mellitus describes a condition where the body cannot produce insulin which leads to a very high level of blood sugar and associated complications. The condition, which usually develops in childhood or adolescence, affects millions of people worldwide.

Read More

Overview

Feature Articles

Latest Type 1 Diabetes News and Research

Study could offer a new way to treat Type 1 and Type 2 diabetes

Study could offer a new way to treat Type 1 and Type 2 diabetes

New AI algorithm to fully automate the artificial pancreas system

New AI algorithm to fully automate the artificial pancreas system

Single strain of bacteria may reduce the severity of graft-versus-host disease

Single strain of bacteria may reduce the severity of graft-versus-host disease

Study: Children with Type 1 diabetes have lower brain volume, verbal IQ, and overall IQ

Study: Children with Type 1 diabetes have lower brain volume, verbal IQ, and overall IQ

Inherited genetic variation may affect the response to cancer immunotherapy

Inherited genetic variation may affect the response to cancer immunotherapy

Immune responses to insulin could help identify individuals at risk for developing type 1 diabetes

Immune responses to insulin could help identify individuals at risk for developing type 1 diabetes

Study finds cancer as the leading cause of death among patients with diabetes

Study finds cancer as the leading cause of death among patients with diabetes

Study: Diabetics worry about disruption to insulin supplies owing to Brexit outcome

Study: Diabetics worry about disruption to insulin supplies owing to Brexit outcome

Hybrid closed-loop insulin therapy improves glycemic control in adolescents, young adults

Hybrid closed-loop insulin therapy improves glycemic control in adolescents, young adults

Socioeconomic disparities, structural racism impact health care for children with type 1 diabetes

Socioeconomic disparities, structural racism impact health care for children with type 1 diabetes

New review supports stricter control of HbA1C levels among children with type 1 diabetes

New review supports stricter control of HbA1C levels among children with type 1 diabetes

iTHRIV announces recipients of  health research pilot projects

iTHRIV announces recipients of health research pilot projects

Study reveals racial-ethnic inequities among people with type 1 diabetes and COVID-19

Study reveals racial-ethnic inequities among people with type 1 diabetes and COVID-19

Common gene expression changes at target tissues of four autoimmune diseases found

Common gene expression changes at target tissues of four autoimmune diseases found

New approach can help identify novel treatments for autoimmune diseases

New approach can help identify novel treatments for autoimmune diseases

UC-MSC infusions reduce risk of death, quicken recovery time in severe COVID-19 cases

UC-MSC infusions reduce risk of death, quicken recovery time in severe COVID-19 cases

Routine eye imaging may provide clues to cognitive disorders in older people with type 1 diabetes

Routine eye imaging may provide clues to cognitive disorders in older people with type 1 diabetes

Researchers demonstrate potential preventive treatment for Crohn's disease

Researchers demonstrate potential preventive treatment for Crohn's disease

Intensive interventions in type 2 diabetes reduce risk of cardiovascular autonomic neuropathy

Intensive interventions in type 2 diabetes reduce risk of cardiovascular autonomic neuropathy

New screening platform can be used to discover more effective drugs for type 1 diabetes

New screening platform can be used to discover more effective drugs for type 1 diabetes